Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Free full text

Full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Comparative Study

Clinical Trial

Review

Research Support, N.I.H., Extramural

Randomized Controlled Trial

Meta-Analysis

Clinical Trial, Phase II

Case Reports

Research Support, U.S. Gov't, P.H.S.

Video-Audio Media

Publication Year

From

Quick links

Individual year

2025

2021

2017

2016

2014

2012

2011

2009

2008

2006

2005

2004

2002

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Proviruses""[mesh_terms]

20 Results

Searching titles within these results

Targeting Epigenetics to Cure HIV-1: Lessons From (and for) Cancer Treatment.

J Peter Svensson

Frontiers in cellular and infection microbiology 2021;11():668637

Free Full Text

Abstract

Molecular evolution of the tre recombinase.

Frank Buchholz

Journal of visualized experiments : JoVE 2009

Free Full Text

Abstract

Vpr, accessory protein of human immunodeficiency virus type 1 (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus-1): features of genetic variants of the virus circulating in the Moscow region in 2019-2020.

A I Kuznetsova, A A Antonova, E A Makeeva, K V Kim, I M Munchak, E N Mezhenskaya, E A Orlova-Morozova, A Y Pronin, A G Prilipov, O V Galzitskaya

Voprosy virusologii 2025;70(4):324-339

Full Text

Abstract

Progressive emergence of an S153F plus R263K combination of integrase mutations in the proviral DNA of one individual successfully treated with dolutegravir.

Thibault Mesplède, Marcelo A Soares, Jean-Pierre Routy, Esmeralda A Soares, Hanh T Pham, Brunna M Alves, Sunbin Yoo, Meng A Xiao, Jing Leng, Peter K Quashie

The Journal of antimicrobial chemotherapy 2021;76(3):639-647

Full Text

Abstract

Changing sensitivity to broadly neutralizing antibodies b12, 2G12, 2F5, and 4E10 of primary subtype B human immunodeficiency virus type 1 variants in the natural course of infection.

Evelien M Bunnik, Marit J van Gils, Marilie S D Lobbrecht, Linaida Pisas, Ad C van Nuenen, Hanneke Schuitemaker

Virology 2009;390(2):348-55

Free Full Text

Abstract

Proviral HIV-genome-wide and pol-gene specific zinc finger nucleases: usability for targeted HIV gene therapy.

Misaki Wayengera

Theoretical biology & medical modelling 2012;8():26

Free Full Text

Abstract

Nucleotide and amino acid mutations in human immunodeficiency virus corresponding to CD4+ decline.

M D Hill, W Hernández

Archives of virology 2006;151(6):1149-58

Full Text

Abstract

Inhibitors of strand transfer that prevent integration and inhibit human T-cell leukemia virus type 1 early replication.

Samira Rabaaoui, Fatima Zouhiri, Agnès Lançon, Hervé Leh, Jean d'Angelo, Eric Wattel

Antimicrobial agents and chemotherapy 2009;52(10):3532-41

Free Full Text

Abstract

Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial.

Tatsufumi Nakamura, Tomohiro Matsuo, Taku Fukuda, Shinji Yamato, Kentaro Yamaguchi, Ikuo Kinoshita, Toshio Matsuzaki, Yoshihiro Nishiura, Kunihiko Nagasato, Tomoko Narita-Masuda, Hideki Nakamura, Katsuya Satoh, Hitoshi Sasaki, Hideki Sakai, Atsushi Kawakami

BMC medicine 2014;11():182

Free Full Text

Abstract

In vivo, in vitro, and in silico analysis of methylation of the HIV-1 provirus.

Leonard Chávez, Steven Kauder, Eric Verdin

Methods (San Diego, Calif.) 2011;53(1):47-53

Free Full Text

Abstract

Techniques used to identify the Brazilian variant of HIV-1 subtype B.

S Komninakis, L Fukumori, R Alcalde, M Cortina, L Abdala, A Brito, S Sanabani, A J S Duarte, J Casseb

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica 2008;40(3):301-4

Free Full Text

Abstract

Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.

A Marcello, M Zoppé, M Giacca

IUBMB life 2002;51(3):175-81

Free Full Text

Abstract

The polymorphic nature of HIV type 1 env V4 affects the patterns of potential N-glycosylation sites in proviral DNA at the intrahost level.

Manon Belair, Magali Dovat, Brian Foley, Claude Mayerat, Giuseppe Pantaleo, Cecilia Graziosi

AIDS research and human retroviruses 2009;25(2):199-206

Full Text

Abstract

HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA.

Guilherme C Oliveira, Sieberth Nascimento-Brito, Jean Paulo Zukurov, Juliana T Maricato, Angela C Volpini, Anna Christina M Salim, Flávio M G Araújo, Roney S Coimbra, Fernando Antoneli, Luiz Mário R Janini

PloS one 2016;10(9):e0139037

Free Full Text

Abstract

Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses.

Hanh T Pham, Thibault Mesplède, Mark A Wainberg

Retrovirology 2017;13(1):31

Free Full Text

Abstract

Results: 1 – 15 / 20

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Proviruses""[mesh_terms]

Targeting Epigenetics to Cure HIV-1: Lessons From (and for) Cancer Treatment.

Molecular evolution of the tre recombinase.

Vpr, accessory protein of human immunodeficiency virus type 1 (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus-1): features of genetic variants of the virus circulating in the Moscow region in 2019-2020.

Progressive emergence of an S153F plus R263K combination of integrase mutations in the proviral DNA of one individual successfully treated with dolutegravir.

Changing sensitivity to broadly neutralizing antibodies b12, 2G12, 2F5, and 4E10 of primary subtype B human immunodeficiency virus type 1 variants in the natural course of infection.

Proviral HIV-genome-wide and pol-gene specific zinc finger nucleases: usability for targeted HIV gene therapy.

Nucleotide and amino acid mutations in human immunodeficiency virus corresponding to CD4+ decline.

Inhibitors of strand transfer that prevent integration and inhibit human T-cell leukemia virus type 1 early replication.

Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial.

In vivo, in vitro, and in silico analysis of methylation of the HIV-1 provirus.

Techniques used to identify the Brazilian variant of HIV-1 subtype B.

Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.

The polymorphic nature of HIV type 1 env V4 affects the patterns of potential N-glycosylation sites in proviral DNA at the intrahost level.

HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA.

Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses.

Results for
""Proviruses""[mesh_terms]